Douglas Roblin to Osteoporosis
This is a "connection" page, showing publications Douglas Roblin has written about Osteoporosis.
Connection Strength
1.751
-
Evaluation of a "Just-in-Time" Nurse Consultation on Bone Health: A Pilot Randomized Controlled Trial. Perm J. 2017; 21:16-112.
Score: 0.543
-
Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale. Osteoporos Int. 2017 Dec; 28(12):3379-3388.
Score: 0.142
-
The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial. Osteoporos Int. 2017 10; 28(10):3061-3066.
Score: 0.140
-
Racial Differences and Disparities in Osteoporosis-related Bone Health: Results From the PAADRN Randomized Controlled Trial. Med Care. 2017 06; 55(6):561-568.
Score: 0.140
-
The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial. Osteoporos Int. 2017 10; 28(10):3055-3060.
Score: 0.140
-
Understanding Preferences for Osteoporosis Information to Develop an Osteoporosis Patient Education Brochure. Perm J. 2017; 21:16-024.
Score: 0.135
-
Effects of a DXA result letter on satisfaction, quality of life, and osteoporosis knowledge: a randomized controlled trial. BMC Musculoskelet Disord. 2016 08 26; 17(1):369.
Score: 0.132
-
Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial. Osteoporos Int. 2016 12; 27(12):3513-3524.
Score: 0.131
-
Effect of self-referral on bone mineral density testing and osteoporosis treatment. Med Care. 2014 Aug; 52(8):743-50.
Score: 0.115
-
The PAADRN study: a design for a randomized controlled practical clinical trial to improve bone health. Contemp Clin Trials. 2013 Jan; 34(1):90-100.
Score: 0.101
-
Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled Trial. J Clin Densitom. 2017 Oct - Dec; 20(4):464-471.
Score: 0.033